Network Integrated Platform for Clinical Trials Navigation from the New South Wales Early Phase Clinical Trials Alliance.

Jia Liu¹, Max Farrow¹, Sandra S Hsing², Rasha Cosman³, Charlotte R Lemech⁴, Christina Teng⁵, Abhijit Pal⁶, Udit Nindra⁷, Andrew Ohyama Parsonson⁸, John J W Park⁹, Anthony Rodrigues¹, Wei Y Chan¹⁰, Joe Wei⁵, Jordan Cohen¹¹, Craig R Underhill¹², Daniel Brungs¹³, Mun Hui¹⁴, Adnan Nagrial¹⁵, Suyog Jain², Anthony M Joshua¹⁶

¹St Vincent's Hospital Sydney Darlinghurst, NSW Australia.

²Guardant (United States) Singapore Singapore.

³St Vincent's Hospital Melbourne Darlinghurst, NSW Australia.

⁴UNSW Sydney Sydney, NSW Australia.

⁵UNSW Sydney Sydney Australia.

⁶Liverpool Hospital Liverpool, NSW Australia.

⁷Western Sydney University Sydney, NSW Australia.

⁸Macquarie University Sydney, NSW Australia.

⁹Macquarie University Sydney Australia.

¹⁰Macquarie University Hospital Sydney, NSW Australia.

¹¹Calvary Mater Newcastle Hospital Newcastle, NSW Australia.

¹²Border Medical Oncology Research Unit Albury, NSW Australia.

¹³Wollongong Hospital Australia.

¹⁴Chris O'Brien Lifehouse Australia.

¹⁵Westmead Hospital Sydney, NSW Australia.

¹⁶The Kinghorn Cancer Centre Darlinghurst, NSW Australia.

PubMed DOI

Abstract

PURPOSE: Access to early-phase clinical trials (EPCTs) is increasingly constrained by delays in genomic testing and lack of coordinated system-level navigation. The New South Wales Early Phase Clinical Trials Alliance (NECTA) was established to improve EPCT access. PANNA-COTA (Practical Assessment of NECTA Network Assistance in Cancer Outpatient Trials Access) prospectively evaluated whether integ…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.